Bristol-Myers Squibb Company

NYSE: BMY
$49.41
+$0.39 (+0.8%)
Closing Price on September 20, 2024

BMY Articles

Frank Golhen, via Wikimedia CommonsMost of the firms that we cover on Wall Street have presented their high conviction stock picks for 2014. The analysts at Credit Suisse have taken a little bit...
ThinkstockThe wave of mergers and acquisitions in health care continues with two big announcements Monday. Drug maker Shire PLC (NASDAQ: SHPG) will acquire the rare disease biopharmaceutical company...
Jon OggEarnings season is in full swing and equities are challenging new highs almost daily. Traders and investors are looking for stocks to buy and for ideas on which stocks to sell. 24/7 Wall St....
ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown and impending debt ceiling weighed heavily on biotech stocks....
ThinkstockAs the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum of the parts analysis for their...
U.S. equity markets opened barely higher this morning following a report that mortgage loan applications had fallen by 9.8% from the previous week, on top of a 7% decline for the prior period. In...
Investors and traders are always looking for new research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research calls each morning to find great ideas from...
U.S. equity markets opened slightly lower this morning following a number of data releases related to the U.S. economy. Producer prices declined in April and the New York manufacturing index came in...
ThinkstockOne of the downsides to a market that seems to go up every day is knowing what stocks to own or sell as the market chugs higher. One strategy for investors to consider is keep a weighting...
Wikimedia CommonsYesterday’s announcement by Pfizer Inc. (NYSE: PFE) that it would begin selling its blockbuster Viagra drug online directly to patients is a genuinely ground-breaking deal. The big...
ThinkstockWith the markets making new highs seemingly every day, it is understandable that investors may be finding it harder and harder to find stocks that do not appear overvalued, or at a minimum...
ThinkstockAccording to the Center for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese. Obesity-related medical conditions include heart attack, stroke,...
Jon OggArgus is truly considered to be independent research firm, so it is not full of the traditional possible conflicts on interest seen in other Wall Street broker sell-side drive research. The...
Jon OggThese are some of this Monday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) raised to Neutral at J.P....
President Obama suggests cuts in Social Security and Medicare to end a battle over budget cuts. (Reuters) Bristol-Myers Squibb Co. (NYSE: BMY) may try a large acquisition to improve its fortunes....